coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Warrington Central East PCN, Warrington (LAD) · Health Inequalities Profile

    PCN U29000 · NHS Cheshire and Merseyside Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    27,823

    Registered population

    61.4% aged 18–64

    20.1%

    Aged 65+

    ICB 19.0% · England 17.9%

    5.8%

    Ethnic minority (non-White)

    2.7% Asian · England 9.6%

    22.8%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~3,741

    Core20 residents (est.)

    Resident basis; registered basis ~6,878 · see page 3

    5,339

    Hypertension register

    +5.85% in 3 yrs · England +5.60%

    275

    SMI register

    12.3% of Warrington (LAD)'s

    624

    COPD register

    Reviews -16.04% in 3 yrs

    Forecast to 2030

    5,982

    Hypertension patients, 2030

    +643 on today

    67.6%

    QRISK ≥20% on statins, 2030

    +1.50pp over 3 yrs

    4.4%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -16.0%
    Respiratory annual review rates fell over three years.

    COPD reviews fell 16.0% to 68.8% (England 76.4 percent) and asthma reviews fell 13.3% to 58.4% (about 810 unreviewed patients), which may reflect recall.

    71.7 pp
    Core20 share and phone access vary across practices.

    Core20 share spans 71.7 pp from Holes Lane Medical Ltd.

    78.2%
    Breast, cervical screening and hypertension control beat England.

    Breast screening reaches 78.2% (England 69.9 percent), cervical screening reaches 73.6% (England 66.8 percent), and hypertension treated to target is 71.6% (England 70.3 percent).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients comprise 20.1% of the list alongside 94.2% White resident ethnicity

    Warrington Central East PCN has 27,823 registered patients, with 20.1% (5,589 patients) aged 65+, above Warrington (LAD) (17.5%), the ICB (19.0%) and England (17.9%). Projected population growth to 2030 is 0.1%, below Warrington (LAD) (0.7%), the ICB (2.3%) and England (2.3%), though projection methodology is unverified. Area Census resident data indicates 94.2% White ethnicity (Warrington (LAD) 93.5%, the ICB 93.0%, England 81.1%) and a 5.8% ethnic minority share, led by Asian or Asian British residents at 2.7% (Warrington (LAD) 3.3%, the ICB 2.8%, England 9.6%). These resident figures reflect catchment populations rather than registered patients.

    Age profile

    0–1718.5%
    18–6461.4%
    65+20.1%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White94.2%
    Asian2.7%
    Mixed1.4%
    Other0.9%
    Black0.8%

    Older people · falls rows are Warrington (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Warrington LA)1,7372,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)79.8%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.8%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Warrington LA)9051,0219552024/25
    Falls deaths, all ages, per 100,000 (Warrington LA)12.118.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Registered Core20 share is 22.8% overall yet spans 71.7 pp across practices

    Registered Core20 share is 22.8% (Warrington (LAD) 16.9 percent, ICB 31.9 percent, England 21.0 percent), but practice shares span 71.7 pp, from 7.2% at Holes Lane Medical Ltd. to 78.9% at Cockhedge Medical Centre (2,217 estimated Core20 patients). Greenbank Surgery accounts for 2,003 estimated patients at 25.9% share. Practice estimates sum to 6,878, whereas associated-resident deciles 1 and 2 estimate 3,741. Reconciling resident and registered bases is essential before targeting outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Cockhedge78.9% · 2,217 patients
    Fairfield26.7% · 1,047 patients
    Greenbank25.9% · 2,003 patients
    Manchester Road25.4% · 906 patients
    Holes Lane7.2% · 705 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    275

    SMI register

    0.95% recorded prevalence

    139

    Learning disability register

    0.48% recorded prevalence

    7

    Care homes, 329 beds

    In the PCN catchment

    9.4%

    Provide unpaid care

    Warrington (LAD), Census 2021

    Learning disability prevalence is 0.5% (139 patients), against 0.5% in Warrington, 0.6% in the ICB and 0.6% in England. Severe mental illness prevalence is 0.9% (275 patients), trailing Warrington (1.0%), the ICB (1.1%) and England (1.0%). The PCN catchment includes 7 care homes with 329 beds.

    Severe mental illness: physical health checks

    Although SMI blood pressure checks reached 86.3% (England 83.4%), BMI recording fell 0.02 pp over 2023 to 2025 (England +5.1 pp). Greenbank Surgery recorded 76.3% for blood pressure, consistent with uneven physical health monitoring across practices.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,339

    Hypertension register

    +5.85%

    Register growth, 3 yrs

    Warrington (LAD) +6.41% · England +5.60%

    +2.38pp

    BP control, under 80

    ≤140/90 · −0.85pp aged 80+

    +643

    More patients by 2030

    Forecast 5,982 (20.77%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 18.5% (5,339 patients), above Warrington (16.4%), the ICB (16.8%) and England (15.2%). While 71.6% of patients are treated to target (England 70.3%), recent blood pressure recording stands at 85.9%, trailing England (90.0%) and the ICB (88.3%). Furthermore, control in patients aged 80+ fell 0.8 pp (England +1.8 pp) over 2023 to 2025. Trailing recent monitoring and falling control in patients aged 80+ point to an opportunity to prioritise systematic blood pressure recall for older cohorts.

    Lipids and statins

    Patients with QRISK ≥ 20% on lipid-lowering therapy reached 64.5%, above England (63.6%) and Warrington (61.6%), though three-year growth was +2.4% (England +6.2%). CKD treatment stands at 73.3% (England 70.3%). Slower uptake growth than England highlights an opportunity to audit and expand recall for high-risk primary prevention patients.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202649,422£1.70£1.71£1.86£84,017
    Cardiovascular (all), 202569,511£5.48£4.37£3.33£380,920

    In 2026, 49,422 lipid-modifying items were prescribed at £1.70 per item (Warrington £1.59, ICB £1.71, England £1.86), spending £7,908 less than at England's unit cost. Spending less per item than England reflects low unit drug expenditure, meaning clinical review and treatment reach should remain the priority.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −13.32%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.28%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 2.2% (624 patients; England 1.9%), growing +10.2% over 2023 to 2025 (England +2.6%). However, annual COPD reviews fell 16.0% to 68.8% (England 76.4%, England change +2.8%). Similarly, asthma reviews fell 13.3% over 2023 to 2025 to 58.4% (England 65.7%, England change +4.4%), leaving an estimated scale of about 810 unreviewed patients across the 1,942 register. Paediatric asthma prescribing reached 1,840 items per 1,000 aged 5-19 (England 1,488). Falling review rates alongside growing registers could reflect recall capacity pressures, which an audit would test.

    Cancer register and children's immunisation

    Cancer prevalence is 3.9% (1,127 patients; England 3.8%), growing +6.0% over 2023 to 2025 (England +9.0%). In Q1 2025/26, childhood immunisations trail the 95.0% target: 6-in-1 coverage at 12 months is 88.7% (England 91.0%), MMR dose 2 at age 5 is 87.7% (England 82.8%), and 4-in-1 pre-school booster coverage is 81.5% (England 80.9%). Small quarterly cohorts limit causal conclusions, but pre-school booster shortfalls warrant targeted recall.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months88.7%

    England 91.0%

    6-in-1 complete primary course at 24 months88.6%

    England 92.2%

    MMR dose 1 at 24 months88.6%

    England 88.3%

    MMR dose 2 at age 587.7%

    England 82.8%

    4-in-1 pre-school booster at age 581.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Across NHS Cheshire and Merseyside ICB in 2022, 55.5% of staged cancers (7,482 of 13,490 with known stage) were diagnosed at stage 1 or 2, against 55.3% in England and 19.5 pp below the 75.0% national ambition. Known-stage share was 72.8% across 18,522 registered cancers. Early detection reached 87.1% in breast cancer but 44.9% in bowel cancer. PCN breast screening is 78.2% and cervical screening is 73.6%. Over 2023 to 2025, PCN cancer register growth was +6.0% (England +9.0%), whereas Cockhedge Medical Centre recorded -2.8%. Slower register growth could reflect non-screened presentation delays; a clinical audit would test this.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, North Cheshire and Mersey NHS Foundation Trust achieved 83.7% on the 62-day cancer referral to treatment standard, below the 85.0% standard by 1.3 pp, but exceeding Mersey and West Lancashire Teaching Hospitals NHS Trust (78.0%), Manchester University NHS Foundation Trust (72.8%), the ICB (76.2%) and England (71.2%). Its 28-day faster diagnosis reached 80.2% (standard 75.0%). Diagnostic 6-week waits were low for MRI (0.5%) and CT (2.3%), though echocardiography reached 28.0% (England 28.5%). These provider metrics describe acute system timeliness rather than PCN-specific patient pathways.

    Pathways within standard (%)North Cheshire and MerseyMersey and West LancashireManchesterCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)80.2172.3980.0677.2579.32
    31-day treatment (96%)98.1795.4692.5495.7192.50
    62-day referral to treatment (85%)83.6777.9672.8576.2371.16
    Diagnostic waits over 6 weeks (%)North Cheshire and MerseyMersey and West LancashireManchesterEngland
    MRI0.5314.0411.6821.40
    CT2.3213.0814.669.92
    Echocardiography28.0434.884.9128.48
    Colonoscopy15.9818.044.5130.83
    Gastroscopy20.2418.1729.3529.02
    All 15 DM01 tests6.3421.178.9823.14
    Community services activityWarrington residentsCheshire and Merseyside ICB
    Care contacts38,550541,280
    Referrals7,32097,150
    Patients with a contact14,830146,240

    Community services (residents of Warrington), Jun 2026 (provisional). In June 2026, adults aged 65+ accounted for 56% of community service contacts among Warrington borough residents (21,595 of 38,550 total contacts). This activity captures borough-wide resident contacts rather than PCN-registered activity, highlighting substantial community operational demand concentrated in older age groups across the local system.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 41.8 pp while vaccination achievement ranges by 62.9 pp

    For 2025/26, the range in QOF vaccination and immunisation-domain achievement from Manchester Road Surgery to Holes Lane Medical Ltd. was 62.9 pp. Achievement was 37.1% at Manchester Road Surgery, while achievement was 100.0% at Holes Lane Medical Ltd.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Manchester Road9325.475.5%58.0%86.2%
    Holes Lane1147.268.5%61.1%81.0%
    Cockhedge8178.989.6%77.2%80.9%
    Fairfield Surgery10626.775.2%68.5%77.1%
    Greenbank Surgery11225.947.8%70.3%63.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWarrington (LAD)AssetPCNWarrington (LAD)
    Care homes (catchment)7 (329 beds)n/aSchools (catchment)45n/a
    Children's centres412Places of worship2289
    Libraries17Primary schools (LA maintained)728
    Primary academies731Special schools11

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma and COPD review recall

    Asthma reviews are 58.4% (England 65.7%; register 1,942, about 810 unreviewed) after falling 13.3% over 2023 to 2025; COPD reviews fell 16.0% to 68.8% (England 76.4%; register 624). For discussion: run a respiratory recall audit, offering flexible review slots and pairing inhaler checks with high-Core20 practice lists. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    Two-list Core20 and telephony access review

    Practice Core20 share spans 71.7 pp (7.2% at Holes Lane Medical Ltd. to 78.9% at Cockhedge Medical Centre); phone access spans 41.8 pp (47.8% at Greenbank Surgery to 89.6% at Cockhedge Medical Centre). Low cost, quick to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 3

    Older adult cardiovascular and frailty recall

    Recent BP recording is 85.9% (England 90.0%; PCN register 5,339), 80+ BP control fell 0.8 pp (England +1.8 pp), heart failure reviews fell 9.0% to 78.7%, and frail diabetes HbA1c control is 79.8% (England 81.9%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult frailty capacity review (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Reconciled Core20 targeting audit (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical health recall audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePractice
    Hypertension recall audit (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall audit (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer referral and presentation audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Practice telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Structured asthma and COPD review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · COPD registerCore20PLUS5 respiratoryPCN
    Option 2 · Two-list Core20 and telephony access review (p12)Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phoneCore20PLUS5 · 10YHP equity test · 10YHP, hospital to communityPCN & Practice
    Option 3 · Older adult cardiovascular and frailty recall (p12)Hypertension register · Hypertension patients with a recent BP reading · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15